Summary of CME Group Inc. (NASDAQ:CME) Ratings on May 17, 2018

May 17, 2018 - By Alma Kearns

CME Group Inc. (NASDAQ:CME) Corporate Logo
During 2017 Q4 the big money sentiment increased to 1.15. That’s change of 0.14, from 2017Q3’s 1.01. 29 investors sold all, 224 reduced holdings as CME Group Inc. ratio is positive. 212 rose positions while 78 funds took positions. Funds hold 265.76 million shares thus 0.05% less from 2017Q3’s 265.89 million shares.
Moneta Group Inc Investment Advisors Ltd Llc has 3 shs. Voya Investment Mngmt Limited Liability Corp stated it has 0.04% of its capital in CME Group Inc. (NASDAQ:CME). Aureus Asset Management invested 2.13% in CME Group Inc. (NASDAQ:CME). Smithfield Trust has invested 0% in CME Group Inc. (NASDAQ:CME). Andra Ap holds 0.23% or 68,656 shs in its capital. Bb&T Corp has 0.01% invested in CME Group Inc. (NASDAQ:CME) for 3,595 shs. Northwest Investment Counselors Lc holds 0.85% in CME Group Inc. (NASDAQ:CME) or 14,397 shs. 3,813 were reported by Gofen And Glossberg Ltd Liability Il. Moreover, Plante Moran Financial Advsr Limited Com has 0.04% invested in CME Group Inc. (NASDAQ:CME). First Washington Corporation reported 3,782 shs stake. America First Investment Advsrs Ltd Liability Co reported 5.6% in CME Group Inc. (NASDAQ:CME). Paradigm Asset Mngmt Limited Liability Company stated it has 0.02% in CME Group Inc. (NASDAQ:CME). Cap International Sarl has invested 2.28% in CME Group Inc. (NASDAQ:CME). Commonwealth Of Pennsylvania School Empls Retrmt holds 0.06% of its capital in CME Group Inc. (NASDAQ:CME) for 30,438 shs. Citadel Advsrs Lc has 0.06% invested in CME Group Inc. (NASDAQ:CME).

CME Group Inc. had 10 insider sales and 0 insider purchases since December 18, 2017. This’s net activity of $9.68 million. On Tuesday, January 9 $1.14M worth of stock was sold by Pietrowicz John W.. 20,000 CME Group Inc. (NASDAQ:CME) shs with value of $3.03M were sold by DUFFY TERRENCE A. On Friday, February 2 2,400 shs were sold by Sammann Derek, worth $387,972. MELAMED LEO sold $1.14M worth of stock or 7,300 shs. Kometer Kevin sold 16,105 shs worth $2.61M. Piell Hilda Harris sold $539,452 worth of stock.

CME Group Inc. (NASDAQ:CME) Ratings Coverage

Total analysts of 9 have positions in CME Group (NASDAQ:CME) as follows: 7 rated it a “Buy”, 0 with “Sell” and 2 with “Hold”. The positive are 78%. Since December 21, 2017 according to StockzIntelligence Inc CME Group has 15 analyst reports. In Friday, April 6 report Deutsche Bank maintained it with “Buy” rating and $197 target. On Thursday, February 1 Sandler O’Neill maintained CME Group Inc. (NASDAQ:CME) with “Buy” rating. On Monday, February 26 the stock of CME Group Inc. (NASDAQ:CME) earned “Hold” rating by Keefe Bruyette & Woods. On Thursday, March 8 the rating was maintained by Bank of America with “Buy”. On Friday, February 2 the stock has “Buy” rating by Bank of America. On Friday, February 2 the firm has “Hold” rating given by Keefe Bruyette & Woods. On Friday, March 9 the stock has “Buy” rating by Jefferies. On Friday, March 2 the stock of CME Group Inc. (NASDAQ:CME) has “Buy” rating given by Sandler O’Neill. On Thursday, December 21 Keefe Bruyette & Woods maintained CME Group Inc. (NASDAQ:CME) rating. Keefe Bruyette & Woods has “Hold” rating and $160.0 target. On Wednesday, February 7 the stock of CME Group Inc. (NASDAQ:CME) has “Buy” rating given by Goldman Sachs. Listed here are CME Group Inc. (NASDAQ:CME) PTs and latest ratings.

10/04/2018 Broker: Jefferies Rating: Buy New Target: $190.0000 Maintain
10/04/2018 Broker: Bernstein Rating: Outperform New Target: $190 Initiates Coverage On
06/04/2018 Broker: Deutsche Bank Old Rating: Buy New Rating: Buy Old Target: $185 New Target: $197 Maintain
09/03/2018 Broker: Jefferies Rating: Buy New Target: $187.0 Maintain
08/03/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $175 New Target: $185 Maintain
02/03/2018 Broker: Sandler O’Neill Rating: Buy New Target: $185.0 Maintain
26/02/2018 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $168.0 Maintain
07/02/2018 Broker: Goldman Sachs Rating: Buy New Target: $180.0 Upgrade
02/02/2018 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $161.0 Maintain
02/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $173 New Target: $175 Maintain

Ticker’s shares touched $160.7 during the last trading session after 0.02% change.Currently CME Group Inc. is uptrending after 37.71% change in last May 17, 2017. CME has 809,992 shares volume. CME outperformed the S&P500 by 26.16%.

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.The firm is valued at $54.72 billion. The firm offers a range of products across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals.13.46 is the P/E ratio. The Company’s products include exchange-traded; and privately negotiated futures and options contracts and swaps.

A couple more CME Group Inc. (NASDAQ:CME) news were announced by: Fool.com which released on April 27, 2018 “CME Group (CME) Q1 2018 Earnings Conference Call Transcript”, also Nasdaq.com on April 21, 2018 announced “3 Ways to Play Cryptocurrencies Without Actually Buying Them”, the next Seekingalpha.com is “CME: Great Business, But Grossly Overvalued” on May 08, 2018. Fool.com has article titled “CME Group Benefits From the Return of Market Volatility”.

CME Group Inc. (NASDAQ:CME) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.